source
- China IIT deaths prompt lawmakers to request FDA clampdownTwo Republican lawmakers are asking the FDA to reject clinical data from China unless a trial site has been recently audited by the agency, and to institute a sweeping review of existing products’…Endpoints · 17m ago↗ source
- Replimune lands commercial chief after hard-fought approval; Neumora's Paul Berns sheds CEO title→ Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer, effective Aug. 18. DiNapoli formerly worked at Genentech and led ...Endpoints · 17m ago↗ source
- Moderna's cancer vaccine boost lifts stock, sparks talk of Keytruda-like reachModerna’s shares surged 177% after a phase 3 topline win for its Merck‑partnered cancer vaccine, intismeran autogene, was disclosed. The data, released on Wednesday, added roughly $45 billion to Mo…